Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS BBG USD EM Sovereign UCITS ETF USD dis
LU1324516050 · LU1324516050 · USD · domicile Luxembourg
Bonds · Government USD · Broad (all maturities) · Emerging marketsSFDR art. 6
Index tracked: Bloomberg Emerging Markets USD Sovereign & Agency 3% Country Capped Index
- TER
- 0.25%+ trans. 0.04%
- Fund size
- 106 m EUR
- Tracking difference
- −0.27%3-year avg
- 🇮🇹 tax rate
- 18.49%white list 55.60%
- Replication
- Physical (mixed: optimised/sampled)
- Income
- Distributingsemi-annual
- Duration
- 6.19 yrsmedium (3–7 years)
Launch 29 Jan 2016 · costs from the KID as of 2 Sept 2026 · 927 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and will take proportionate exposure on the components of the Bloomberg Emerging Markets USD Sovereign & Agency 3% Country Capped Index (Total Return) using a stratified approach (stratified sampling strategy) by investing in a representative sample of components of the index selected by the portfolio manager using a 'portfolio optimisation' technique. The proportionate exposure by the Fund to the component securities will be substantially achieved either through direct investment or through the use of derivatives or through…
Performance since series start (in euro) — base 100
29 Jan 2016 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +7.8% |
| 3 years | +25.6% |
| 5 years | +13.1% |
| 10 years | +31.7% |
| Since series start | +47.2% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 5.90% | 6.94% | 7.90% |
| Max drawdown | −6.15% | −8.59% | −34.30% |
| Sharpe | -0.34 | 0.08 | -0.86 |
| Sortino | -0.40 | 0.09 | -1.05 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU1324516050 · LU13245160501
RebalixLU1324516050 · LU1324516050 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +14.81% | +15.01% | −0.20% |
| 2024 | +7.85% | +8.06% | −0.21% |
| 2023 | +11.65% | +12.06% | −0.41% |
| 2022 | −19.05% | −19.45% | +0.39% |
| 2021 | −2.74% | −2.20% | −0.54% |
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 0.6296 USD (6.77% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.6296 | — |
| 2025 | 2 | 0.7136 | +7.81% |
| 2024 | 2 | 0.5835 | +6.46% |
| 2023 | 2 | 0.5811 | +6.72% |
| 2022 | 2 | 0.5286 | +4.69% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
SBEM · Borsa Italiana (ETFplus)
UEFS · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 14 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · www.ubs.com/2/e/files/lux_etf_pe.pdf
The live sheet, always up to date
rebalix.com/en/etf/LU1324516050
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1324516050
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU1324516050 · LU13245160502